Berman Howard's most recent trade in Atea Pharmaceuticals Inc was a trade of 37,700 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 18, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Atea Pharma Inc | Howard Berman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2026 | 37,700 | 37,700 | - | - | Stock Option (Right to Buy) | |
| Atea Pharma Inc | Howard Berman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2026 | 26,700 | 26,700 | - | - | Restricted Stock Units | |
| Coya Therapeutics Inc | Howard Berman | Director, Executive Chairman | 22 Jan 2026 | 15,257 | 15,257 | - | - | Stock Option (right to buy) | ||
| Atea Pharma Inc | Howard Berman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2025 | 164,800 | 164,800 | - | - | Stock Option (Right to Buy) | |
| Coya Therapeutics Inc | Howard Berman | Director | 09 Jan 2025 | 150,602 | 150,602 | - | - | Stock Option (right to buy) | ||
| Coya Therapeutics Inc | Howard Berman | Director, Chief Executive Officer | 03 Jun 2024 | 163,663 | 163,663 | - | - | Stock Option (right to buy) | ||
| Coya Therapeutics Inc | Berman Howard | Director, Chief Executive Officer | 31 Jan 2024 | 189,680 | 189,680 | - | - | Stock Option (right to buy) | ||
| Coya Therapeutics Inc | Howard Berman | Director, Chief Executive Officer | 27 Feb 2023 | 165,000 | 165,000 | - | - | Stock Option (right to buy) |